Concepedia

Jay B. Fell

JB

14

Publications

2.9K

Citations

13

H-Index

1995

Active since

Affiliations

Array BioPharma (United States)(Current)

Roche (United States)

Mirati Therapeutics (United States)

Tris Pharma (United States)

Jay B. Fell is an author at Array BioPharma (United States) specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

1995–2021

14

Publications

14

The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients

Jill Hallin, Lars D. Engstrom, Lauren Hargis et al. · Cancer Discovery · 2019 · 1.2K citations · Full text

Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS <sup>G12D</sup> Inhibitor

Xiaolun Wang, Shelley Allen, James F. Blake et al. · Journal of Medicinal Chemistry · 2021 · 644 citations · Full text

Identification of the Clinical Development Candidate <b>MRTX849</b>, a Covalent KRAS<sup>G12C</sup> Inhibitor for the Treatment of Cancer

Jay B. Fell, John P. Fischer, Brian R. Baer et al. · Journal of Medicinal Chemistry · 2020 · 559 citations · Full text

Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo Activity

Jay B. Fell, John P. Fischer, Brian R. Baer et al. · ACS Medicinal Chemistry Letters · 2018 · 104 citations · Full text

Progression of Organic Reactions on Resin Supports Monitored by Single Bead FTIR Microspectroscopy

Bing Yan, Jay B. Fell, G. Kumaravel · The Journal of Organic Chemistry · 1996 · 80 citations

, , +14

Rows per page

1–5 of 14